|
LMSP05010134
|
Cerebroside C
|
N-(2-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-9-methyl-sphinga-4E,8E-dienine
|
Neutral glycosphingolipids [SP05]
|
Simple Glc series [SP0501]
|
753.58
|
C43H79NO9
|
|
LMSP05010092
|
Chrysogeside D
|
N-(2R-hydroxy-3E-nonadecenoyl)-1-beta-D-glucopyranosyl-9-methyl-heptadecasphing-4E,8E-dienine
|
Neutral glycosphingolipids [SP05]
|
Simple Glc series [SP0501]
|
753.58
|
C43H79NO9
|
|
LMSP05010117
|
Flavicerebroside B
|
N-(2R-hydroxy-3E-octadecenoyl)-1-beta-D-galactosyl-9-methyl-sphing-4E,8E-dienine
|
Neutral glycosphingolipids [SP05]
|
Simple Glc series [SP0501]
|
753.58
|
C43H79NO9
|
|
LMSP05010156
|
Flavuside B
|
N-(2R-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-10-methyl-sphinga-4E,9E-dienine
|
Neutral glycosphingolipids [SP05]
|
Simple Glc series [SP0501]
|
753.58
|
C43H79NO9
|
|
LMSP0501AC24
|
GalCer(d18:2(4E,8E)(9Me)/18:1(3E)(2OH[S]))
|
N-(2S-hydroxy-3E-octadecenoyl)-1-beta-galactosyl-4E,8E-9-methyl-octadecasphingadienine
|
Neutral glycosphingolipids [SP05]
|
Simple Glc series [SP0501]
|
753.58
|
C43H79NO9
|
|
LMSP0501AA82
|
GlcCer(d18:2(4E,8E)(9Me)/18:1(3E)(2OH[S]))
|
N-(2S-hydroxy-3E-octadecenoyl)-1-beta-glucosyl-4E,8E-9-methyl-octadecasphingadienine
|
Neutral glycosphingolipids [SP05]
|
Simple Glc series [SP0501]
|
753.58
|
C43H79NO9
|
|
LMSP05010172
|
|
N-(2R-hydroxy-octadecanoyl)-1-beta-D-glucosyl-9-methyl-sphing-4E,8E,10E-trienine
|
Neutral glycosphingolipids [SP05]
|
Simple Glc series [SP0501]
|
753.58
|
C43H79NO9
|